Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Looking for quick-paying work from home jobs? Explore opportunities that allow you to earn fast from home.
20,735 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A federal judge blocked the Trump-era SNAP limits on soda and candy, delaying a controversial nutrition policy that w...
When a Veeco director sells a large block, it sparks questions. This article explains what insider trades mean, how t...
Cynthia Lummis gave clarity on timing for the CLARITY Act, but the Senate path remains uncertain as lawmakers juggle ...
A former Meta public policy director alleges the company spied on her for more than a year to suppress discussion of ...
As the nation marks its 250th birthday, Anthony Scaramucci urges a return to thrift and steady investing to protect h...
A fresh industry snapshot shows the typical enterprise AI outlay hits $11.5 million per year, but most firms cannot d...
Wealthy investors are tightening tax planning in 2026, leaning on advisers and new strategies to shield gains and boo...
A retiree with a $1.3 million 401(K) balance faced a sharp, year-one tax spike driven by RMDs, Social Security taxati...
Vanguard’s International High Dividend Yield ETF has raised payouts in 2025 and 2026, but the durability of its forei...
As 2026 unfolds, investors face a choice between DoorDash and Lyft. This article breaks down growth, margins, and ris...
From a kitchen studio to a coveted CEO audience, this profile traces how David Senra built podcast influence by leani...